Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
The Lancet — Wolter N, Jassat W, Walaza S, et al. | January 31, 2022
In South Africa, there was identification of the SARS-CoV-2 omicron variant of concern in November, 2021, which was linked with a rise in COVID-19 cases. In this study, the clinical severity of infections with the omicron variant was determined using S gene target failure (SGTF) on the Thermo Fisher Scientific TaqPath COVID-19 PCR test as a proxy.
Data linkages were conducted for national, South African COVID-19 case data, SARS-CoV-2 laboratory test data, SARS-CoV-2 genome data, and COVID-19 hospital admissions data.
A total of 161,328 cases of COVID-19 were reported from October 1 (week 39) to December 6 (week 49), 2021.
TaqPath PCR tests were used to diagnose 38,282 people and identification of 29,721 SGTF infections and 1,412 non-SGTF infections was made.
Individuals with SGTF were noted to be at significantly reduced risks of hospitalization vs those diagnosed non-SGTF infections during the same time period.
There appeared significantly reduced odds of severe disease among SGTF-infected individuals vs with individuals infected earlier with the delta variant.
Previous immunity may have resulted in some of this reduced severity.
Read the full article on The Lancet